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Tetanus (TeNT) is a zinc protease that blocks neurotransmission by cleaving the synaptic protein
vesicle-associated membrane protein/synaptobrevin. Although its intracellular catalytic activity
is well established, the mechanism by which this neurotoxin interacts with the neuronal surface
is not known. In this study, we characterize p15s, the first plasma membrane TeNT binding
proteins and we show that they are glycosylphosphatidylinositol-anchored glycoproteins in nerve
growth factor (NGF)-differentiated PC12 cells, spinal cord cells, and purified motor neurons. We
identify p15 as neuronal Thy-1 in NGF-differentiated PC12 cells. Fluorescence lifetime imaging
microscopy measurements confirm the close association of the binding domain of TeNT and Thy-1
at the plasma membrane. We find that TeNT is recruited to detergent-insoluble lipid microdo-
mains on the surface of neuronal cells. Finally, we show that cholesterol depletion affects a raft
subpool and blocks the internalization and intracellular activity of the toxin. Our results indicate
that TeNT interacts with target cells by binding to lipid rafts and that cholesterol is required for
TeNT internalization and/or trafficking in neurons.
INTRODUCTION
Tetanus (TeNT) and botulinum neurotoxins (BoNTs) block
neurotransmitter release and are responsible for tetanus and
botulism, respectively. These toxins share a common struc-
ture comprised of a heavy (H, 100 kDa) and a light (L, 50
kDa) chain linked by a disulfide bond. The H chain mediates
binding and internalization in neurons, whereas the L chain
is a metallo-protease that selectively cleaves synaptic pro-
teins (Niemann et al., 1994; Schiavo et al., 2000). TeNT and
BoNTs bind to the neuromuscular junction, but their intra-
cellular actions take place at different levels of the nervous
system. TeNT undergoes retrograde transport to the cell
body of spinal cord motor neurons (MNs), is transcytosed,
and cleaves the synaptic vesicle protein vesicle-associated
membrane protein (VAMP)/synaptobrevin in inhibitory
synapses. Instead, BoNTs act at a peripheral level by block-
ing acetylcholine release at the motor nerve terminal. This
differential sorting has been interpreted as a consequence of
binding to different surface receptors (Habermann and
Dreyer, 1986; Herreros et al., 1999).
TeNT and BoNTs bind to polysialogangliosides of the G1b
series (Halpern and Neale, 1995). However, the fact that
their binding is sensitive to proteases (Lazarovici and Yavin,
1986; Pierce et al., 1986; Yavin and Nathan, 1986) suggests
the existence of specific protein receptors. Thus, a model in
which TeNT and BoNTs interact with a complex constituted
by both lipid and protein receptors has been proposed
(Montecucco, 1986). Despite several efforts, these protein
receptors have not been conclusively identified. Several
BoNT serotypes interact with synaptotagmins (Nishiki et al.,
1994; Li and Singh, 1998), but the role of these proteins as
physiological BoNT receptors remains controversial (Evans
et al., 1986; Bakry et al., 1997). We have previously followed
a cross-linking approach (Schiavo et al., 1991) to demonstrate
that the binding domain of TeNT (TeNT HC) interacts with
a glycoprotein of 15 kDa (p15) in nerve growth factor
(NGF)-differentiated PC12 cells and spinal cord MNs (Her-
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reros et al., 2000a). In these neuronal cell types p15 showed
the behavior of an integral membrane protein (Herreros et
al., 2000a).
Several toxins, including cholera toxin (CT) (Orlandi and
Fishman, 1998; Wolf et al., 1998; Shogomori and Futerman,
2001) and all the known pore-forming toxins (Fivaz et al.,
1999; Gordon et al., 1999), bind to lipid raft components.
Furthermore, some bacteria and viruses enter cells via lipid
rafts (Dehio et al., 1995; Baorto et al., 1997; Parton and Lind-
say, 1999; Shin et al., 2000). Lipid rafts are microdomains of
the plasma membrane enriched in sphingolipids (including
gangliosides), cholesterol, and glycosylphosphatidylinositol
(GPI)-anchored proteins (Brown and London, 2000; Simons
and Toomre, 2000). They have been implicated in vesicular
sorting, trafficking to the apical membrane, and signaling
(reviewed in Simons and Ikonen, 1997; Simons and Toomre,
2000). Recently, several lines of evidence have supported the
role of cholesterol in the control of intracellular membrane
trafficking (Grimmer et al., 2000; Hoekstra and van Ijzen-
doorn, 2000; Mukherjee and Maxfield, 2000; Simons and
Gruenberg, 2000).
Here, we characterize the cross-linking products contain-
ing TeNT HC and p15 to show that p15s are GPI-anchored
proteins in different neuronal cell types. Immunoprecipita-
tion experiments identify p15 as Thy-1, a GPI-anchored neu-
ronal raft protein (Williams and Gagnon, 1982; Madore et al.,
1999) in NGF-differentiated PC12 cells. The association of
TeNT HC with Thy-1 at the plasma membrane is confirmed
by fluorescence resonance energy transfer (FRET) measure-
ments with the use of fluorescence lifetime imaging micros-
copy (FLIM). Cell-bound TeNT HC and Thy-1 are found in
detergent-insoluble glycolipid-enriched (DIGs) fractions,
which represent in vitro isolated lipid rafts (Brown and
London, 2000). Furthermore, we show that cholesterol de-
pletion causes the displacement of TeNT HC from a DIG
subpool and protects neurons from the toxic activity of
TeNT in vivo.
MATERIALS AND METHODS
Materials
Recombinant TeNT HC fragments were produced and radiolabeled
with [-32P]ATP as previously described (Lalli et al., 1999; Herreros
et al., 2000a). TeNT was purified and biotinylated as in Arribas et al.
(1993). Aerolysin and anti-aerolysin antibodies were kindly pro-
vided by Dr. G. van der Goot (University of Geneva, Geneva,
Switzerland). Monoclonal antibody against GAP-43 (clone NM4)
was from Autogen Bioclear (Calne, Wilshire, United Kingdom) and
anti-HPC-1/syntaxin-1 and anti-SNAP-25 antibodies were a kind
gift from T.H. So¨llner (Memorial Sloan-Kettering Cancer Center,
New York, NY).
Binding, Cross-linking, and Immunoprecipitation
Rat pheochromocytoma (PC12) cells were differentiated with 75
ng/ml 7S NGF (Alomone, Jerusalem, Israel) for 6–7 d. Spinal cord
MNs were purified from E14 rat embryos and mouse spinal cord
cells were isolated from E13 mice embryos (Lalli et al., 1999; Herre-
ros et al., 2000a).
For phosphoinositol-phospholipase C (PI-PLC) treatment, cells were
washed in serum-free medium, pretreated (1 h, 37°C) with different
amounts of PI-PLC (Sigma, Poole, Dorset, United Kingdom) and ex-
tensively washed. Cells were cooled on ice, washed with Hanks’ buffer
(Herreros et al., 2000a), and incubated (1 h, 4°C) with 300 pM 32P-
labeled TeNT HC in Hanks’ buffer containing 0.2% bovine serum
albumin. After binding, cells were washed and cross-linked (10 min,
4°C) with 0.22 mM bis[2(succinimidyloxycarbonyloxy)ethyl]sulfone
(Perbio-Science, Tatten Hall, Cheshire, United Kingdom) in Hanks’
buffer. The reaction was stopped and cells were solubilized as previ-
ously described (Herreros et al., 2000a). Proteins were analyzed in
6–12% acrylamide gradient gels followed by autoradiography.
In immunoprecipitation experiments, selected samples were in-
cubated with 1 nM CT (1 h, 4°C) after 32P-labeled TeNT HC binding
and cross-linking. Cells were scraped in Hanks’ buffer containing 1
mM Pefabloc (Roche Molecular Biochemicals, Mannheim, Germa-
ny), 1 mM iodoacetamide, 1 mM benzamidine, 1 g/ml aprotinin, 1
g/ml leupeptin, and phosphatase inhibitors cocktail (all from Sig-
ma). Samples were pelleted down and solubilized (30 min, 4°C)
with 4% octyl--d-glucopyranoside, 0.5% Triton X-100 (TX-100) in
Hanks’ buffer plus inhibitors. After centrifugation (10,000 rpm, 10
min), supernatants were incubated (2 h, 4°C) with protein G or
protein A beads precoupled with monoclonal anti-vesicular stoma-
titis virus protein G (VSV-G) (Herreros et al., 2000a), anti-Thy-1
(clone OX7), anti-CT (Biogenesis, Pool, Dorset, United Kingdom),
and mock antibodies or affinity-purified polyclonal anti-PrP anti-
bodies (Affinity Bioreagents, Golden, CO), respectively. Beads were
extensively washed with detergent-containing Hanks’ buffer. In
some cases, an additional wash with 1 M urea was performed after
the detergent washes. Beads were resuspended in SDS-sample
buffer and analyzed as described above.
Isolation of DIGs and Western Blot
PC12 cells (seeded at 110 cells/mm2) were treated with NGF for 6–7
d. A total of 3.9  106 mouse spinal cord neurons was cultured for
2 wk before the experiment. Cells were washed and in selected cases
pretreated (1 h, 37°C) with 4.5 mM methyl--cyclodextrin (MCDX;
Sigma) in serum-free medium. After extensive washing, 300 pM
TeNT 32P-HC or 1 nM biotinylated-TeNT (b-TeNT) was bound as
mentioned above. Cells were washed with Hanks’ buffer and resus-
pended in 1 ml (PC12) or 0.25 ml (spinal cord cells) of 1% TX-100 in
Hanks’ buffer plus inhibitors. Cells were solubilized (30 min, 4°C),
the cell lysate was adjusted to 41% sucrose in Hanks’ buffer, and
overlaid with 8.5 ml of 35% sucrose and 2.5 ml of 16% sucrose. DIGs
were isolated by ultracentrifugation (35,000 rpm, 18 h, 4°C; Abrami
et al., 1998). Then 11–12 fractions of 1 ml were collected, precipitated
with 6.5% trichloroacetic acid in the presence of 0.05% sodium
deoxycholate (Sigma), and washed with 80% cold acetone. Samples
were analyzed by SDS-PAGE followed by Western blot and auto-
radiography. b-TeNT was detected with the use of streptavidin-
peroxidase (1.25 g/ml; Sigma). Western blots were developed with
the use of the enhanced chemiluminescence method (Amersham
Pharmacia Biotech UK, Little Chalfont, Buckinghamshire, United
Kingdom). Alternatively, in the case of mouse spinal cord cells, gels
were rinsed for 20 min with 50 mM Tris-HCl, pH 7.4, 20% glycerol
and transferred to nitrocellulose (5 h, 150 mA) in 10 mM NaHCO3,
3 mM Na2CO3, pH 9.8 (Abrami et al., 1998). Blots were rinsed with
binding buffer (50 mM NaH2PO4, pH 7.5, 0.3% Tween 20) and
incubated with aerolysin (2 nM, 2 h), followed by washing and
Western blot with the use of anti-aerolysin antibodies.
For cross-linking experiments, fractions 2–5 (DIGs) and 9 –12
(soluble) were pooled and cross-linked with 0.5 mM
bis[2(succinimidyloxycarbonyloxy)ethyl]sulfone (10 min, 4°C,
under shaking). The reaction was stopped with 30 mM glycine
and samples were analyzed as described above.
Immunofluorescence
Fab fragment from the OX7 clone was purified with the use of the
ImmunoPure Fab Preparation kit, according to manufacturer’s in-
structions (Perbio-Science). Direct conjugation of IgG and Fab to
Cy3 and Cy5 fluorophores (Amersham Pharmacia Biotech UK) was
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performed at pH 8.5 (IgG) or pH 9.0 (Fab) as described previously
(Bastiaens and Jovin, 1998).
Cells were incubated with either TeNT HC (80–120 nM at 4 or
37°C) or CT (2 nM, 1 h, 4°C) and fixed with 3.7% paraformaldehyde
(10 min at room temperature). TeNT HC was immunodetected with
the use of purified monoclonal antibodies against the VSV-G
epitope as previously described (Lalli et al., 1999). CT in Figure 4
was detected by with the use of anti-CT polyclonal antibodies
(Sigma). When permeabilization was needed, cells were incubated
with 0.1% TX-100 for 5 min. Texas Red- (Amersham Pharmacia
Biotech UK) or Alexa 488-coupled secondary antibodies (Molecular
Probes, Eugene, OR) were used according to manufacturer’s in-
structions. Cells were visualized through a Plan-APOCHROMAT,
63/1.4 numerical aperture phase 3 oil objective with the use of a
laser scanning confocal microscope (Zeiss LSM 510; Zeiss, Jena,
Germany). Images correspond to selected optical sections (collected
in the z-axis at intervals of 0.4 m).
FRET Determination by FLIM
For FLIM measurements, immunocytochemical staining was per-
formed as described above, without cell permeabilization, and in-
cluded an additional fixation with 3.7% paraformaldehyde before
mounting. A detailed description of the FLIM apparatus used for
FRET determination can be found elsewhere (Squire and Bastiaens,
1999). The lifetime instrument performs phase- and modulation-
based imaging fluorometry by microscopy. All images were taken
with the use of a Zeiss Plan-APOCHROMAT 100/1.4 numerical
aperture phase 3 oil objective and the homodyne phase-sensitive
images recorded at a modulation frequency of 80.224 MHz. Donors
(Cy3-labeled monoclonal anti-VSV-G or anti-CT IgGs) were excited
with the use of the 414 nm line of an argon/krypton laser and the
resultant fluorescence separated with the use of a combination of
dichroic beamsplitter (HQ 565 LP; Chroma, Brattleboro, VT) and
emission filter (HQ 610/75; Chroma). Acceptor images (Cy5-anti
Thy-1 Fab) were recorded with the use of a 100-W mercury arc lamp
(Zeiss Attoarc) as a source of sample illumination combined with a
high Q Cy3 filter set (exciter, HQ 620/60; dichroic, HQ 660 LP;
emitter, HQ 700/75 LP; Chroma).
TeNT Intoxication and VAMP Cleavage
Mouse spinal cord cells (10–12 d in culture) were pretreated with 2
or 4.5 mM MCDX (1 h, 37°C) in serum-free medium and washed.
The effect of adding cholesterol–MCDX complexes could not be
assessed because this treatment was toxic in spinal cells. Treated
and untreated cells were incubated with 200 pM TeNT (20 h, 37°C)
in serum-free medium. Cells were scraped in Hanks’ buffer plus
Pefabloc and proteins recovered by trichloroacetic acid precipita-
tion. Samples were analyzed by SDS-PAGE containing urea and
Western blot with the use of anti-VAMP-2 monoclonal antibodies
(Edelmann et al., 1995). VAMP/synaptobrevin immunoreactivity
was quantified with the use of NIH Image 1.61 and normalized to
syntaxin-1 for equal loading.
Transferrin Uptake
MCDX-treated and untreated spinal cord cells were assessed for
125I-transferrin uptake (human diferric form; 670 ng/ml;
PerkinElmer Life Science Products, Boston, MA) in serum-free me-
dium at 4°C or 37°C for different times. After two rounds of acid
wash (0.2 M acetic acid, 0.5 M NaCl, pH 2.5) (Hopkins and Trow-
bridge, 1983) for 2 min on ice followed by a wash in medium, cell
lysates were recovered in 1 M NaOH and counted in a gamma
counter (Packard Instrument, Meriden, CT). Counts represent en-
docytosed transferrin. Competition was tested with the use of 200
excess of human holotranferrin (Sigma).
RESULTS
p15s Are GPI-anchored TeNT HC Binding Proteins
We recently demonstrated that cross-linking products very
similar in size are formed after binding of 32P-labeled TeNT
HC (Figure 1A) to NGF-differentiated PC12 cells, rat MNs,
and mouse spinal cord cells (Herreros et al., 2000a). These
results indicated the interaction of TeNT HC (48 kDa) with a
protein of an apparent molecular weight of 15 kDa (p15) in
different cell types. p15s are N-glycosylated and behave as
integral membrane proteins in detergent-partitioning exper-
iments (Herreros et al., 2000a). This last property of p15
could be mediated by the presence of transmembrane do-
main(s) or by various forms of covalent lipid modification.
GPI-anchored proteins are abundant components of the
plasma membrane, behaving as integral membrane proteins.
Their biochemical analysis is simplified by the use of PI-
PLC, an enzyme that causes their selective release from the
membrane. We therefore tested the possibility that p15s are
GPI-anchored proteins. Pretreatment with PI-PLC before
TeNT HC binding and cross-linking inhibited the formation
of the previously characterized 65 kDa cross-linking prod-
uct in NGF-differentiated PC12 cells in a dose-dependent
manner (Figure 1B, filled arrowhead), whereas total binding
was not significantly affected (Figure 1B, empty arrowhead).
Formation of the corresponding cross-linking products in
MNs and spinal cord cells (Figure 1B, filled arrowheads)
was also inhibited by PI-PLC pretreatment. These results
indicate that p15s, proteins interacting with TeNT HC in our
cross-linking assays, are GPI-anchored proteins in all three
neuronal cell types.
p15 Is Thy-1 in NGF-differentiated PC12 Cells
In our attempts to identify p15s, we searched for known
proteins with the properties described above. Among others,
Thy-1 (Williams and Gagnon, 1982), a major cell-surface
GPI-anchored glycoprotein of 25–29 kDa present in thymo-
cytes and brain and expressed in PC12 cells (Jeng et al.,
1998), represented a likely candidate. To test whether p15 is
Thy-1, immunoprecipitation experiments with a panel of
different antibodies was performed in NGF-differentiated
PC12 cells (Figure 2A). As expected, antibodies against the
VSV-G tag of TeNT HC pulled down both the unmodified
binding fragment and the 65-kDa cross-linking product
(Figure 2A). The 65-kDa cross-linking band was specifi-
cally recovered with monoclonal antibodies against Thy-1,
but not with mock antibodies or with antibodies against PrP,
a GPI-anchored protein similar in size to Thy-1 (Figure 2A).
Antibodies against CT, which binds to GM1 and is used as
a raft marker, did not immunoprecipitate the cross-linking
product (Figure 2A), indicating that lipid rafts had been
disrupted by solubilization with octyl--d-glucopyranoside
under our experimental conditions (Arni et al., 1998; Simons
et al., 1999; Simons and Toomre, 2000). Furthermore, incu-
bation of cells with both CT and TeNT HC followed by
cross-linking did not result in the appearance of additional
cross-linking products (our unpublished results). These
findings suggest that the cross-linking of TeNT HC to Thy-1
is not a consequence of high local concentration or proximity
but rather due to their direct interaction. Interestingly, anti-
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Thy-1 antibodies coimmunoprecipited a fraction of TeNT
HC that could not be dissociated from the beads with 1 M
urea (Figure 2A), suggesting a strong interaction between
Thy-1 and TeNT HC. Moreover, the decrease in Thy-1 im-
munoreactivity after PI-PLC treatment of NGF-differenti-
ated PC12 cells strictly correlated with the inhibition of the
formation of the65-kDa cross-linking product (our unpub-
lished results). The apparent molecular weight of the cross-
linking product is lower that the sum of the individual
components (48 and 25 kDa). Anomalous migration of cross-
linking adducts in SDS-PAGE has been reported (Tate and
Khadse, 1987) and is dependent on the nature of the inter-
acting proteins surfaces and the generation of conforma-
tional constrains stable in denaturing conditions.
We have previously demonstrated that the carboxyl-ter-
minal subdomain of TeNT HC (HCC; Figure 1A) is necessary
and sufficient for binding to p15 (Herreros et al., 2000b).
Consistently, anti-Thy-1 but not mock monoclonal antibod-
ies immunoprecipitated the cross-linking product obtained
after binding of 32P-labeled HCC to NGF-differentiated PC12
cells (Figure 2B).
The interaction of TeNT HC with Thy-1 in its membrane
environment was further analyzed by FLIM (Figure 3). With
the use of FLIM, we determined the extent of FRET between
a Cy3-labeled IgG directed against the VSV-G epitope of
TeNT HC (donor) and a Cy5-conjugated IgG Fab fragment
recognizing Thy-1 (acceptor). FRET results in a shortening of
the donor fluorescence lifetime, which is measured by two
independent parameters, the phase shift (p) and relative
modulation depth (m). FRET is only detected between two
proteins that are closely associated or complexed in vivo,
typically within 10 nm (Selvin, 2000). NGF-differentiated
PC12 cells were stained with a Cy3-VSV-G IgG to visualize
cell-bound TeNT HC after incubation with the toxin for 1 h
at 4°C or 30 min at 37°C either alone, or together with a
Cy5-labeled anti-Thy-1 Fab fragment. The fluorescence life-
time, , measured as the average phase shift and relative
modulation depth [(p  m)/2] for Cy3-VSV-G antibodies
was decreased at punctate structures (see below) of the
plasma membrane (Figure 3, A and B, right). This was
particularly evident when TeNT HC had been incubated
with the cells at 37°C. The presence of FRET was confirmed
by photobleaching the Cy5 acceptor, resulting in a length-
ening of the lifetime of the donor (our unpublished results).
The FRET efficiency (Eff) pseudocolor plots also indicate that
FRET occurs at the plasma membrane. Statistical analysis of
cumulative results from all the cells analyzed demonstrates
that TeNT HC interacts with Thy-1 at 4°C and that their
association is enhanced at 37°C (see two-dimensional p vs.
m lifetime profiles and pixel counts vs. FRET efficiency plots
in the lower part of Figure 3A). Permeabilized cells (allow-
ing staining of putative intracellular structures) showed the
same FRET efficiency (our unpublished results), indicating
that FRET was due to the interaction of the TeNT HC and
Thy-1 at the plasma membrane. Parallel experiments with
the use of a Cy3-labeled anti-CT IgG to visualize cell-bound
CT either alone or together with a Cy5-labeled anti-Thy-1
Fab fragment showed no significant FRET, compared with
the positive control cells (stained with Cy3-labeled anti-
VSVG IgG against cell-bound TeNT HC/Cy5-labeled anti-
Thy-1 Fab fragment) (Figure 3B), indicating that localization
to lipid rafts per se is not sufficient to produce FRET under
our experimental conditions. Taken together, these results
identify p15 as Thy-1 in NGF-differentiated PC12 cells and
Figure 1. p15s are GPI-anchored
proteins. (A) Schematic represen-
tation of TeNT, the binding frag-
ment HC and the carboxyl-termi-
nal subdomain HCC. (B) Binding
and cross-linking of 32P-labeled
TeNT HC after pretreatment with
increasing doses of PI-PLC in
NGF-differentiated PC12 cells, rat
MNs, and mouse spinal cord
cells. Empty arrowhead indicates
cell-bound TeNT-HC and filled
arrowheads point to the corre-
sponding cross-linking products,
which do not form after PI-PLC
treatment.
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indicate that TeNT HC specifically associates with Thy-1 on
the surface of these cells.
TeNT Interacts with Lipid Rafts
GPI-anchored proteins and gangliosides, together with cho-
lesterol and other sphingolipids, concentrate in microdo-
mains of the plasma membrane called lipid rafts (Jacobson
and Dietrich, 1999; Simons and Toomre, 2000). The interac-
tion of TeNT HC with Thy-1, which is considered a neuronal
raft marker (Aarts et al., 1999; Madore et al., 1999), therefore
suggested that the binding of TeNT to the cell surface could
be mediated by lipid rafts. To test this hypothesis, we first
looked at the distribution of Thy-1 and TeNT HC in NGF-
differentiated PC12 cells. Bound TeNT HC displays a punc-
tate pattern on the plasma membrane (Lalli et al., 1999;
Herreros et al., 2000a), which is reminiscent of lipid rafts
(Mayor et al., 1994; Harder et al., 1998) and is shared by
Thy-1 (Jeng et al., 1998) (Figure 4, a–c). Furthermore, GM1,
another raft marker (Orlandi and Fishman, 1998; Wolf et al.,
1998), showed a partial colocalization with TeNT HC (Figure
4, d–f).
To investigate more directly whether TeNT HC binds to
lipid microdomains, we prepared DIG-enriched mem-
branes. Isolation of DIGs is one of the most widely used
methods for studying lipid rafts (Brown and London, 2000).
DIGs were purified from NGF-differentiated PC12 cells after
binding of 300 pM 32P-labeled TeNT HC and radioactivity
was followed along the gradient fractions. TeNT HC concen-
trated in fractions 2–4 at the top of the gradient (Figure 5A),
corresponding to DIGs. DIG fractions were defined by their
enrichment in Thy-1 (Figure 5A) and other raft markers such
as the ganglioside GM1 or PrP (our unpublished results).
SNAP-25, a palmitoylated plasma membrane protein, re-
mained concentrated in the bottom fractions of the gradient
(Figure 5A), which contain the soluble material and the
majority of proteins. Similarly, only a very small amount of
VAMP/synaptobrevin, an integral membrane protein of
synaptic vesicles, was found in DIGs (Figure 5A; Chamber-
lain et al., 2001). The ability of TeNT HC to reach the top of
the gradient is dependent on the presence of cell lysate (our
unpublished results), indicating that the flotation of TeNT
HC to the lighter fractions is not due to the presence of
detergent and the centrifugation procedure.
To assess whether the interaction of TeNT HC and Thy-1
is stable in the conditions used for DIG isolation, TeNT HC
was bound to NGF-differentiated PC12 cells and then DIGs
or soluble fractions were isolated and used for cross-linking.
DIGs showed the same pattern of cross-linking seen in intact
Figure 2. Thy-1 is p15 in NGF-differentiated PC12
cells. Immunoprecipitation (IP) after binding and
cross-linking (CL) of 32P-labeled TeNT-HC (A) or
HCC (B) with the use of mock antibodies (anti-myc
or anti-HA) or antibodies against VSV-G, Thy-1, CT,
or PrP in NGF-differentiated PC12 cells. Filled ar-
rowheads indicate the position of the corresponding
cross-linking products.
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Figure 3. TeNT HC and Thy-1 association in NGF-differentiated PC12 cells detected by FLIM. NGF-differentiated PC12 cells were incubated with
TeNT HC (1 h at 4°C or 30 min at 37°C) or CT (30 min at 37°C), washed, and then fixed in paraformaldehyde. Cells were stained with a Cy3-labeled
anti-VSV-G IgG (donor) alone (anti-Thy1-Cy5) or together with a Cy5-conjugated anti-Thy1 IgG Fab fragment (anti-Thy1-Cy5) (A and right
panels of B). In parallel experiments, cells were stained with Cy3-labeled anti-CT IgG (donor) alone (anti-Thy1-Cy5) or together with a
Cy5-conjugated anti-Thy-1 IgG Fab fragment (anti-Thy1-Cy5) (B, left). The fluorescence images from the donor (TeNT HC anti-VSV-G-Cy3 or
anti-CT-Cy3) and acceptor (anti-Thy1-Cy5), the donor fluorescence lifetime  and its corresponding pseudocolor scales are shown. Eff is the
pixel-by-pixel FRET efficiency represented on a pseudocolor scale (see details in the text) and the average lifetime of the donor in the absence of
acceptor (D) used to calculate Eff has been taken by averaging six anti-VSVG or anti-CT-Cy3 donor (alone without acceptor) measurements. The
cumulative lifetimes of the donor alone (green) and those measured in the presence of the acceptor fluorophore (red) are plotted on the
two-dimensional histograms (n 7 in A and n 6 in B). The pixel counts versus Eff profiles summarize all the FRET efficiency data observed. FRET
between TeNT HC and Thy-1 is greatly enhanced by incubation at 37°C and is not significant between CT and Thy-1.
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cells (Figure 5B). Both the 65-kDa cross-linking product
representing the interaction of TeNT HC with Thy-1 and the
85-kDa adduct, which is likely to reflect the formation of
HC homodimers (Herreros et al., 2000a), were obtained in
purified DIGs (Figure 5B). In contrast, no cross-linking prod-
ucts were observed in the soluble fraction.
In parallel experiments, b-TeNT was bound to NGF-dif-
ferentiated PC12 cells and DIGs were isolated. As shown for
TeNT HC, b-TeNT was found in DIG fractions, although in
this case the association with DIGs was not complete and
some of the bound toxin remained with the soluble material
(Figure 5C, fractions 10–12). A possible explanation for this
result would be that TeNT binding is more sensitive to
TX-100 solubilization than that of HC due to steric hindrance
caused by the translocation domain of the holotoxin. The
fact that both TeNT HC and TeNT were found in DIGs is
supported by their very similar punctate distribution on the
plasma membrane (Herreros et al., 2000a).
These results indicate that the interaction of TeNT and its
binding fragment HC with the plasma membrane of NGF-
differentiated PC12 cells is mediated by lipid microdomains.
The two identified TeNT ligands, polysialogangliosides and
Thy-1, are clustered in lipid rafts, which could therefore
serve as concentration platforms for the toxin binding. How-
ever, Thy-1 appears to be a dispensable component of the
machinery involved in TeNT binding to the neuronal sur-
face. In fact, anti-Thy-1 antibodies were not able to immu-
noprecipitate the cross-linking product of TeNT HC with a
GPI-anchored protein present on the surface of MNs (our
unpublished results), indicating that p15 is not Thy-1 in
these cells (see DISCUSSION). TeNT interaction with Thy-1
and other GPI-anchored proteins could therefore be inter-
preted as an indication of the entry of the toxin in a raft
environment and used as a probe to follow the recruitment
of TeNT into lipid microdomains.
TeNT Binds to Lipid Rafts in Spinal Neurons
Our observations on the interaction of TeNT HC with GPI-
anchored proteins in all the different cell types tested
prompted us to investigate TeNT recruitment to lipid mi-
crodomains in neurons. We prepared DIGs from mouse
spinal cord cells, a mixed culture that has been extensively
used for the study of TeNT binding and internalization (Lalli
et al., 1999; Williamson et al., 1999). After binding of TeNT
HC, isolated DIGs contained 60% of the total bound toxin
and the majority of Thy-1.2 (the mouse allotype for Thy-1;
Figure 6) as detected by overlay with the GPI-binding toxin
aerolysin (Abrami et al., 1998). A small subpool of TeNT HC
was found in fractions containing soluble proteins at the
bottom of the gradient, possibly reflecting differences in the
lipid composition of spinal cord and NGF-differentiated
PC12 cells (Figure 6).
Cholesterol Depletion Protects Neurons from TeNT
Intoxication
The use of cholesterol-sequestering drugs to disrupt mem-
brane rafts is well established (reviewed in Simons and
Toomre, 2000). Studies with these drugs led to the conclu-
sion that cholesterol plays a key structural role in the lipid
microdomain architecture (Schroeder et al., 1998), although
some raft components appear resistant to these drugs in
nonneuronal cells (Abrami and van der Goot, 1999; Lipardi
et al., 2000).
Mouse spinal cord cells were pretreated with MCDX, a
drug that extracts cholesterol from the membranes (Neufeld
et al., 1996), before binding of TeNT HC and isolation of
DIGs. Under these conditions GAP-43, a palmitoylated pro-
tein of the neuronal membrane, was completely extracted
from DIGs (Laux et al., 2000) and represents a positive
control for the treatment (Figure 7; compare left and right,
bottom panels). Interestingly, preincubation with MCDX in-
Figure 4. TeNT HC binding colocal-
izes with the raft markers Thy-1 and
GM1. Binding of TeNT HC (1 h, 4°C)
was revealed with the use of Cy3 la-
beled-monoclonal anti-VSV-G antibod-
ies (b) or Texas Red-coupled secondary
antibodies (e) in nonpermeabilized
NGF-differentiated PC12 cells. Thy-1
immunoreactivity was detected with
the use of Cy5-labeled anti-Thy-1 Fab
(a) (staining is shown in green pseudo-
color). GM1 was detected by CT bind-
ing (d; 1 h, 4°C) followed by polyclonal
anti-CT and Alexa 488-coupled sec-
ondary antibodies. Overlaps are
shown in c and f (colocalization ap-
pears in yellow). Confocal images cor-
respond to single z-sections taken at a
similar distance from the substrate.
Bar, 10 m.
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duced a moderate, but consistent, shift of TeNT HC from
DIGs to the soluble fractions of the gradient (Figure 7). The
increase in the solubility of TeNT HC correlates with an
increase in Thy-1.2 in the same fractions. These results indi-
cate that distinct raft components are differently affected by
cholesterol depletion and suggest that in spinal cord cells
TeNT HC binds to distinct lipid rafts subpools, which dis-
play different sensitivities to MDCX.
After the effect of MCDX on the recruitment of TeNT HC
to DIGs, we investigated whether cholesterol plays a role in
the internalization or intracellular sorting of TeNT. Pretreat-
ment of spinal cord cells with MCDX inhibited the internal-
ization of TeNT HC as shown by immunofluorescence (Fig-
ure 8A). Endocytic structures labeled with TeNT HC in
control cells (which are internal in single confocal z-sections;
Figure 8A) were greatly reduced in MCDX-treated neurons,
Figure 5. TeNT HC and TeNT are found in DIGs
isolated from NGF-differentiated PC12 cells. (A)
Bound 32P-labeled TeNT HC (300 pM) concentrates
in the lighter fractions (2–4; DIGs) of the gradient
(see MATERIALS AND METHODS), which contain
the majority of Thy-1. In contrast, SNAP-25 and
VAMP are mainly found in soluble fractions (11 and
12). (B) TeNT HC and Thy-1 interact in isolated DIGs.
The cross-linking (CL) pattern observed in intact
NGF-differentiated PC12 cells (total) is reproduced
when DIGs (pooled fractions 2–5) but not the soluble
fractions (9–12) were used for cross-linking. Filled
arrowhead indicates the 65-kDa cross-linking
product representing the interaction of TeNT HC
with Thy-1 and the asterisk points to the 83-kDa
cross-linking band corresponding to TeNT HC ho-
modimers. (C) b-TeNT (1 nM) is found in the lighter
fractions (2–5) of the gradient where it comigrates
with Thy-1 and also in fractions 11–12. The band
showed corresponds to the H chain of b-TeNT.
Figure 6. TeNT HC fragment associate with DIGs in
spinal cord cells. TeNT HC (300 pM) concentrates in
DIGs and only a small portion is found in the soluble
fractions. Thy-1.2, the mouse Thy-1 allotype (which is
not recognized by OX7 anti-Thy-1 antibodies), was
detected with the use of the GPI-binding toxin aeroly-
sin (Abrami et al., 1998; see MATERIALS AND METH-
ODS) and its identification among other GPI-anchored
proteins was inferred from the comparison with sam-
ples prepared from Thy-1 knockout cells. Thy-1.2
comigrates with TeNT HC in DIG fractions.
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where TeNT HC was concentrated on the plasma membrane
(Figure 8A). The limited intracellular staining present in
MCDX-treated cells closely resembled the background lev-
els of control samples. These observations suggest that cho-
lesterol depletion inhibits TeNT HC internalization in neu-
rons.
Because MCDX blocked TeNT internalization, we next
asked whether MDCX-treated cells would be protected from
the intracellular zinc-endopeptidase activity of TeNT. We
followed the effect of MDCX preincubation on the proteol-
ysis of VAMP/synaptobrevin, the intracellular target of
TeNT (Schiavo et al., 2000). In spinal cord neurons, 50% of
VAMP is cleaved upon overnight incubation with 200 pM
TeNT, as detected by Western blot with an anti-VAMP
antibody (Figure 8B) (Lalli et al., 1999). This partial cleavage
is due both to the resistance of VAMP to TeNT proteolysis
when engaged in preformed soluble N-ethylmaleimide-sen-
sitive fusion protein-attachment receptor complexes
(SNARE) (Schiavo et al., 2000) and to the contamination of
the neuronal culture with VAMP-containing glial cells (Par-
pura et al., 1995), which are not competent to TeNT intoxi-
cation. Cell pretreatment with 4.5 mM MCDX completely
protected VAMP from TeNT cleavage (Figure 8B). The effect
of MDCX is dose-dependent as demonstrated by the lack of
protection seen with 2 mM MCDX (Figure 8B). We did not
observe any significant change in the recovery of VAMP
after treatment with the drug alone (our unpublished re-
sults). Transferrin uptake in untreated and MCDX-treated
spinal cells was not significantly different (Figure 8C), indi-
cating that under our experimental conditions, this treat-
ment does not affect unspecifically cell functionality or via-
bility (Figure 8C) (see DISCUSSION). Taken together, these
results demonstrate that cholesterol plays a key role in the
internalization of TeNT in spinal cord neurons.
DISCUSSION
In this study, we demonstrate that TeNT HC interacts with
GPI-anchored proteins, p15s, in PC12 cells, spinal cord neu-
rons, and purified MNs. In NGF-differentiated PC12 cells,
we identify p15 as Thy-1 and show by immunoprecipitation
and FLIM experiments that Thy-1 interacts with TeNT HC
and HCC, the HC subdomain sufficient for binding, in this
neuronally differentiated cell line. Thy-1 is a major compo-
nent of neurons and T lymphocytes, where it is expressed in
several distinct glycoforms (Parekh et al., 1987). Thy-1 has
been implicated in multiple processes, including neurite
outgrowth (Tiveron et al., 1992), long-term potentiation
(Nosten-Bertrand et al., 1996), and T-cell receptor signaling
(Hueber et al., 1997). Despite the strong similarities observed
between p15s in different neuronal cell types (Herreros et al.,
2000a), several lines of evidence indicate that Thy-1 is not
the neuronal receptor for TeNT. Spinal cord cells isolated
from Thy-1 knockout mice (Nosten-Bertrand et al., 1996)
show TeNT HC binding and internalization similar to those
isolated from wild-type animals (our unpublished results).
Together with the inability of an anti-Thy-1 antibody to
immunoprecipitate the TeNT HC cross-linking product in
rat MNs (our unpublished results), our findings indicate that
Thy-1 is not an essential component of the TeNT binding
and internalization machinery and suggest that a still un-
identified glycosylated GPI-anchored protein could act as
cellular acceptor for TeNT in MNs.
The identification of GPI-anchored proteins (including
Thy-1) as specific TeNT binding partners and the concentra-
tion of these proteins in lipid rafts led us to investigate the
association of TeNT with lipid microdomains. Several ex-
periments suggest that TeNT binds to lipid rafts. First, the
punctate plasma membrane staining obtained after TeNT
HC binding to NGF-differentiated PC12 cells, spinal cord
cells, and purified MNs is reminiscent of lipid rafts (Mayor
et al., 1994; Harder et al., 1998). Second, TeNT as well as
TeNT HC associates with DIG fractions both in NGF-differ-
entiated PC12 cells and spinal cord neurons. Third, the
interaction of TeNT HC with Thy-1 occurs in DIGs. Finally,
binding of anti-TeNT HC antibody induces clustering in
unfixed cells (our unpublished results), a feature of lipid raft
components (Mayor et al., 1994). In this light, the molecular
interaction between Thy-1 and TeNT HC shown by cross-
linking and FLIM in NGF-differentiated PC12 cells could be
enhanced by the association of both proteins to lipid rafts
(Friedrichson and Kurzchalia, 1998; Varma and Mayor,
1998). FRET efficiency was higher at 37°C than at 4°C, sug-
gesting that physiological temperatures promote a closer
Figure 7. MCDX treatment partially extracts TeNT HC from DIGs in spinal cord cells. TeNT HC is partially solubilized from DIGs (lanes
2 and 3) and its recovery in soluble fractions (lanes 11 and 12) increases accordingly upon MCDX treatment (right). Thy-1.2 follows the same
pattern of TeNT HC before and after MCDX, whereas GAP-43 is completely extracted from DIGs (lanes 2 and 3) by MCDX (bottom right).
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interaction between the two proteins directly or via changes
in the lateral mobility of raft components. We did not how-
ever detect FRET between CT and Thy-1, suggesting that
under our experimental conditions lipid raft clustering is not
sufficient to account for the observed FRET between the
TeNT HC and Thy-1 (Kenworthy et al., 2000).
Some BoNTs have also been found to bind to neuronal
DIGs (Herreros and Schiavo, unpublished results), increas-
ing the possibility that the interaction with lipid microdo-
mains represents a general mechanism for the recruitment of
TeNT and BoNTs to the neuronal membrane.
What is the physiological relevance of TeNT binding to
lipid rafts? These lipid domains have been implicated in
membrane trafficking and signaling (Simons and Ikonen,
1997; Simons and Toomre, 2000). Interestingly, lipid rafts
have recently emerged as membrane domains essential for
the binding and uptake of pathogens and virulence factors
into cells (Dehio et al., 1995; Baorto et al., 1997; Orlandi and
Fishman, 1998; Wolf et al., 1998; Fivaz et al., 1999; Gordon et
al., 1999; Parton and Lindsay, 1999; Ricci et al., 2000; Shin et
al., 2000). A possible explanation for this common mecha-
nism is that binding to lipid rafts promotes a local increase
of the pathogen/toxin’s concentration (Abrami and van der
Goot, 1999), which is exploited by pore-forming and multi-
valent toxins (Fivaz et al., 1999). TeNT binds to polysialo-
gangliosides (Montecucco, 1986; Halpern and Neale, 1995),
which are likely to be concentrated in lipid rafts as demon-
strated for most sphingolipids (Prinetti et al., 2000). PI-PLC
treatment does not affect TeNT HC total binding, suggesting
a role of gangliosides as primary low-affinity TeNT accep-
tors (Williamson et al., 1999) that trap TeNT on the neuronal
surface. Thus lipid rafts, by clustering polysialogangliosides,
GPI-anchored binding proteins, and possibly other proteins
involved in TeNT binding (Lazarovici and Yavin, 1986;
Pierce et al., 1986) could act as concentrating platforms for
TeNT at the plasma membrane. This multiple binding
within lipid rafts could confer to TeNT the extreme high
affinity and neurospecificity observed in vitro and in vivo
Figure 8. MCDX treatment
blocks TeNT HC internalization
and the toxic activity of TeNT in
spinal cord cells. (A) After inter-
nalization of TeNT HC (100 nM,
1 h, 37°C) and permeabilization,
untreated cells show a dotted in-
tracellular staining, detected with
the use of monoclonal anti-VSV-G
antibodies. MCDX-treated (4.5
mM) cell bodies and neurites
exhibit membrane staining but
internalized TeNT HC is not ob-
served. Confocal images corre-
sponding to single z-sections of
0.4 m were taken at the same
distance from the substrate. Bar,
10 m. (B) TeNT-induced cleav-
age of VAMP (compare lane 2 vs.
lane 1) is slightly (lane 3) or com-
pletely protected (lane 4) by pre-
treatment with 2 or 4.5 mM
MCDX, respectively. Syntaxin-1
(isoforms 1a and 1b) is used as a
loading control. Results from four
independent experiments (SD),
normalized for syntaxin-1, are
plotted in the panel below. (C)
125I-Transferrin endocytosis at
37°C is similar in untreated (f)
and MCDX-treated (4.5 mM, o)
spinal cord cells. Results from
two independent experiments
(SD; p  0.05) are shown. 125I-
Transferrin binding (20 min, 4°C)
and residual endocytosis upon
competition with unlabeled trans-
ferrin accounts for 12  3 and
25  3% of maximal endocytosis,
respectively (our unpublished re-
sults).
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(Montecucco, 1986). Furthermore, binding to raft compo-
nents could target CNTs to hot spots on the plasma mem-
brane that would give access to the signaling cascades
emerging from these microdomains. In agreement with this
view, it has been reported that TeNT binding stimulates
phosphorylation of trk A and mitogen-activated protein ki-
nase activity (Gil et al., 2000, 2001). Similar to the signaling
cascades triggered by NGF binding (Huang et al., 1999),
these events are likely to involve lipid rafts.
Depletion of the cellular cholesterol by treatment with
cholesterol-sequestering drugs (MDCX, filipin) or deter-
gents (saponin) disrupts lipid rafts (Neufeld et al., 1996;
Simons and Toomre, 2000) and consequently reduces the
recovery of typical raft components in DIGs (Abrami and
van der Goot, 1999; Huang et al., 1999; Martens et al., 2000).
MDCX treatment of spinal cord cells causes the displace-
ment of a discrete fraction of the bound TeNT HC and other
raft markers from DIGs. These findings suggest the existence
of heterogeneous raft pools on the neuronal membrane (Ma-
dore et al., 1999) that could be differently affected by changes
in the cholesterol content. This moderate increase in the
solubility of TeNT HC correlates with a blockade of its
internalization in MCDX-treated spinal cord cells, suggest-
ing that a specialized subpool of lipid rafts is responsible for
the productive binding and internalization of TeNT. In this
regard, specialized lipid microdomains have been impli-
cated in the internalization of proteins and pathogens (Par-
ton et al., 1994; Baorto et al., 1997) and endocytosis of CT is
inhibited by MCDX in nonneuronal cells (Orlandi and Fish-
man, 1998).
Strikingly, MDCX treatment causes the complete protec-
tion of VAMP from TeNT proteolytic activity, indicating an
essential role of cholesterol in the internalization and intra-
cellular trafficking of the toxin. Although alternative expla-
nations are possible (see below), these findings could now
explain some unique physiological features of TeNT and
BoNTs. One of these properties is the apparent irreversibil-
ity of the binding of these toxins to the neuronal surface
(Schmitt et al., 1981; Habermann and Dreyer, 1986). The
association of TeNT with lipid rafts would be characterized
by a very low dissociation constant due to the multivalent
binding nature of both lipid rafts (containing polysialogan-
gliosides and protein acceptors) and TeNT. Structural anal-
ysis of TeNT HC reveals the presence of multiple binding
sites for oligosaccharides at the extreme carboxy terminus
(Emsley et al., 2000), which is necessary and sufficient for the
interaction with the neuronal surface (Herreros et al., 2000b).
Moreover, TeNT has been described to form homodimers
(Ledoux et al., 1994; Herreros et al., 2000a), a process that
would further strengthen the multimeric nature of these
interactions. In addition, the existence of at least two sub-
populations of TeNT HC that are differently affected by
MDCX treatment could explain the observation of a nonpro-
ductive and productive neurotoxin binding (Daniels-Hol-
gate and Dolly, 1996). The fraction of TeNT interacting with
MDCX-sensitive lipid rafts could thus represent the produc-
tive subpool of TeNT, which is internalized, cleaves VAMP,
and leads to the inhibition of neurotransmitter release.
Recently, MCDX has been reported to inhibit clathrin-
dependent internalization of transferrin in nonneuronal cells
(Rodal et al., 1999; Subtil et al., 1999). The blockade of TeNT
internalization by cholesterol depletion could therefore sug-
gest that TeNT is internalized by a clathrin-dependent path-
way in spinal cord neurons (Parton et al., 1987). MCDX-
treated and control cells showed a similar transferrin
uptake, suggesting that the endosomal recycling pathway is
not affected in our experimental conditions. However, we
cannot completely rule out a possible inhibition of clathrin-
mediated endocytosis in a subset of cells in our mixed spinal
culture. Cholesterol-sequestering drugs also inhibit endocy-
tosis from lipid rafts/caveolae in nonneuronal cells
(Schnitzer et al., 1994; Deckert et al., 1996; Orlandi and Fish-
man, 1998) and GPI-anchored proteins can be internalized
by clathrin-dependent and -independent routes (Makiya et
al., 1992; Mayor et al., 1994; Parton et al., 1994; Skretting et al.,
1999). Thus, TeNT internalization in neurons could involve
both coated and uncoated pathways (Schwab and Thoenen,
1978; Parton et al., 1987).
In conclusion, we demonstrate that TeNT interacts with
GPI-anchored proteins and binds to lipid rafts. Cholesterol
depletion causes the displacement of a subpool of TeNT
from DIGs and blocks the internalization and intracellular
activity of TeNT. This finding highlights a key role of cho-
lesterol in the trafficking of TeNT in neurons.
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